Login / Signup

Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia.

Mariko KobayashiShintaro AkiyamaToshiaki NarasakaKatsumasa KobayashiAtsushi YamauchiAtsuo YamadaJun OmoriTakashi IkeyaTaiki AoyamaNaoyuki TominagaYoshinori SatoTakaaki KishinoNaoki IshiiTsunaki SawadaMasaki MurataAkinari TakaoKazuhiro MizukamiKen KinjoShunji FujimoriTakahiro UotaniMinoru FujitaHiroki SatoSho SuzukiJunnosuke HayasakaTomohiro FunabikiYuzuru KinjoAkira MizukiShu KiyotokiTatsuya MikamiRyosuke GushimaHiroyuki FujiiYuta FuyunoNaohiko GunjiYosuke ToyaKazuyuki NarimatsuNoriaki ManabeKoji NagaikeTetsu KinjoYorinobu SumidaSadahiro FunakoshiKiyonori KobayashiTamotsu MatsuhashiYuga KomakiKuniko MikiKazuhiro WatanabeKiichiro TsuchiyaMitsuru KaiseNaoyoshi Nagata
Published in: Journal of gastroenterology (2022)
Our data showed patients with angioectasia had a greater comorbidity burden and needed more blood transfusions in comparison with those without angioectasia. To reduce rebleeding risk, coagulation therapy can be superior for controlling hematochezia secondary to angioectasia.
Keyphrases
  • genome wide
  • electronic health record
  • cross sectional
  • gene expression
  • stem cells
  • machine learning
  • artificial intelligence
  • cell therapy